GMS Biotech Awarded $105K NHLBI Grant to Validate HLA Typing Platform for ... GenomeWeb GMS believes the project could demonstrate the potential of its technology for use in routine newborn genotyping as well as HLA typing of umbilical cord blood for transplantation and stem cell therapy. Indeed, GMS Chief Scientific Officer Michael Hogan ... |
